These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26205450)

  • 21. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
    Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographically minimal but functionally significant coronary lesion confirmed by optical coherence tomography.
    Yoon HJ; Cho YK; Nam CW; Kim KB; Hur SH
    Korean J Intern Med; 2016 Jul; 31(4):807-8. PubMed ID: 27320616
    [No Abstract]   [Full Text] [Related]  

  • 24. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioresorbable vascular scaffold for ST elevation myocardial infarction: optical coherence tomography observations at the 2-year follow-up.
    Fam JM; Karanasos A; Regar E; van Geuns RJ
    Coron Artery Dis; 2015 Sep; 26(6):545-7. PubMed ID: 25919904
    [No Abstract]   [Full Text] [Related]  

  • 27. Noninvasive Prediction of Atherosclerotic Progression: The PROSPECT-MSCT Study.
    Bourantas CV; Papadopoulou SL; Serruys PW; Sakellarios A; Kitslaar PH; Bizopoulos P; Girasis C; Zhang YJ; de Vries T; Boersma E; Papafaklis MI; Naka KK; Fotiadis DI; Stone GW; Reiber JH; Michalis LK; de Feyter PJ; Garcia-Garcia HM
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):1009-11. PubMed ID: 26363836
    [No Abstract]   [Full Text] [Related]  

  • 28. Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away?
    de Pommereau A; de Hemptinne Q; Varenne O; Picard F
    Arch Cardiovasc Dis; 2018 Apr; 111(4):229-232. PubMed ID: 29678390
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
    Hoppmann P; Kufner S; Cassese S; Wiebe J; Schneider S; Pinieck S; Scheler L; Bernlochner I; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):822-9. PubMed ID: 26708019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recanalized thrombus treated with bioresorbable vascular scaffold: insights from optical coherence tomography.
    Gómez-Monterrosas O; Regueiro A; Santos A; Otsuki S; Scalone G; Fernández-Rodríguez D; Sabaté M
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1453-5. PubMed ID: 25457058
    [No Abstract]   [Full Text] [Related]  

  • 31. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.
    Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613
    [No Abstract]   [Full Text] [Related]  

  • 32. Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds.
    Tanaka A; Jabbour RJ; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1469-1470. PubMed ID: 27085427
    [No Abstract]   [Full Text] [Related]  

  • 33. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence Tomography.
    Capranzano P; Francaviglia B; Radu MD; Capodanno D; Di Salvo ME; Tamburino C
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2123-2124. PubMed ID: 30268872
    [No Abstract]   [Full Text] [Related]  

  • 35. Embolization of Fractured Bioresorbable Scaffold Struts: Insights From 2- and 3-Dimensional Optical Coherence Tomography.
    Capranzano P; Francaviglia B; Capodanno D; Di Salvo ME; Tamburino CI; Santagati FM; Tamburino C
    JACC Cardiovasc Interv; 2016 Feb; 9(4):e37-e38. PubMed ID: 26777323
    [No Abstract]   [Full Text] [Related]  

  • 36. Intra-aortic coronary stent fracture revealed by stent boost imaging and confirmed by multislice computed tomography.
    Pesenti Rossi D; Baron N; Georges JL; Livarek B
    JACC Cardiovasc Interv; 2013 Feb; 6(2):202-3. PubMed ID: 23428014
    [No Abstract]   [Full Text] [Related]  

  • 37. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
    [No Abstract]   [Full Text] [Related]  

  • 38. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Tanaka A; Ruparelia N; Kawamoto H; Sticchi A; Figini F; Carlino M; Chieffo A; Montorfano M; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):832-6. PubMed ID: 26331577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.